4.7 Article

Molecular Epidemiology Reveals Long-Term Changes in HIV Type 1 Subtype B Transmission in Switzerland

期刊

JOURNAL OF INFECTIOUS DISEASES
卷 201, 期 10, 页码 1488-1497

出版社

OXFORD UNIV PRESS INC
DOI: 10.1086/651951

关键词

-

资金

  1. Roche
  2. Abbott
  3. Bristol-Myers Squibb
  4. GlaxoSmithKline
  5. Tibotec
  6. Merck Sharp
  7. Dohme
  8. Swiss HIV Cohort Study (SHCS)
  9. Swiss National Science Foundation (SNF) [3345-062041, 3247B0-112594, 320000116035]
  10. SHCS [470, 528, 569]
  11. Union Bank of Switzerland
  12. European Community's Seventh Framework Programme [pp7/2007-2013, 223131]
  13. Novartis Foundation

向作者/读者索取更多资源

Background. Sequence data from resistance testing offer unique opportunities to characterize the structure of human immunodeficiency virus (HIV) infection epidemics. Methods. We analyzed a representative set of HIV type 1 (HIV-1) subtype B pol sequences from 5700 patients enrolled in the Swiss HIV Cohort Study. We pooled these sequences with the same number of sequences from foreign epidemics, inferred a phylogeny, and identified Swiss transmission clusters as clades having a minimal size of 10 and containing >= 80% Swiss sequences. Results. More than one-half of Swiss patients were included within 60 transmission clusters. Most transmission clusters were significantly dominated by specific transmission routes, which were used to identify the following patient groups: men having sex with men (MSM) (38 transmission clusters; average cluster size, 29 patients) or patients acquiring HIV through heterosexual contact (HETs) and injection drug users (IDUs) (12 transmission clusters; average cluster size, 144 patients). Interestingly, there were no transmission clusters dominated by sequences from HETs only. Although 44% of all HETs who were infected between 1983 and 1986 clustered with injection drug users, this percentage decreased to 18% for 2003-2006 (P < .001), indicating a diminishing role of injection drug users in transmission among HETs over time. Conclusions. Our analysis suggests (1) the absence of a self-sustaining epidemic of HIV-1 subtype B in HETs in Switzerland and (2) a temporally decreasing clustering of HIV infections in HETs and IDUs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据